Recursion Pharmaceuticals shares owned by Wells Fargo & Company
Quarter-by-quarter ownership of Recursion Pharmaceuticals (RXRX) shares owned by Wells Fargo & Company
from 13F filings
Historical chart of Wells Fargo & Company investment in Recursion Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Recursion Pharmaceuticals held by Wells Fargo & Company consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Recursion Pharmaceuticals by Wells Fargo & Company
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-09-30 | $758k | 115k | 6.59 |
| 2024-06-30 | $579k | 77k | 7.50 |
| 2024-03-31 | $583k | 59k | 9.97 |
| 2023-12-31 | $512k | 52k | 9.86 |
| 2023-09-30 | $1.9M | 245k | 7.65 |
| 2023-06-30 | $846k | 113k | 7.47 |
| 2022-12-31 | $16k | 2.0k | 7.71 |
| 2022-09-30 | $20k | 1.7k | 11.55 |
| 2022-06-30 | $12k | 1.4k | 8.47 |
| 2022-03-31 | $72k | 10k | 7.11 |
| 2021-12-31 | $868k | 51k | 17.14 |
| 2021-09-30 | $0 | 13 | 0.00 |